The phrase "access patent" is correct and usable in written English.
It can be used in contexts related to intellectual property, technology, or legal discussions where the ability to utilize or obtain a patent is being referenced.
Example: "The company is seeking an access patent to allow them to use the technology developed by another firm."
Alternatives: "utilization patent" or "licensing patent".
Access patent information via API, bulk download, or data query.
With the development of new Internet databases and the launch of PATOLIS-e, an English-language search service, it has become easier for non-Japanese speakers to access patent information from Japan.
Inventors everywhere are able to not only access patent databases, troves of online technical specifications, and genomic repositories but also take advantage of e-mail and collaborative software tools to brainstorm across borders and tap international markets.
Also, Zoellick lost the support of liberals for his role in the unworkable safeguards on medicines access, patents and public health in developing countries related to the WTO's TRIPS agreement, and conservatives for playing to the gallery of World Bank staffers inimical to any focus on corruption.
Some 65% of researchers had, at some point, needed to access patented technology from another party, and exactly half of the researchers interviewed had themselves been named as inventor on granted patents or on pending patent applications.
In particular, three relationships were largely overlooked during these debates: 1) the relationship between intellectual property protection, TRIPS and innovation; 2) the impact of CAMR on the Canadian domestic economy; and, 3) the relationship of human rights in relation to drug access, patents and TRIPS.
Thus, optimal pricing and purchasing strategies have to be developed while simultaneously incentivizing sustainable quality and supply; this will ensure a balanced market access between patent drugs, off-patent originators, and generics.
At present, the goal in China's pharmaceutical market is to achieve a balanced access across patented drugs, off-patent originators, and generics.
An overview of the development of the remote access to patent information database (RAPID) project is provided.
"We can, and we must, find a reasonable balance between access and patent protection," said Alan F. Holmer, president of the Pharmaceutical Research and Manufacturers of America, a trade group.
Through this program, VanDyne received low-cost office space and free access to patent lawyers and accountants, as well as help developing business plans and raising financing.
